Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data

Background and Purpose: Evidence for induction chemotherapy plus concurrent chemoradiotherapy (IC+CCRT) in nasopharyngeal carcinoma (NPC) was derived from landmark clinical trials excluding the T3N0, T3N1, T4N0 subgroups. This study used Epstein-Barr virus (EBV) DNA to select IC beneficiaries from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Cheng, Zhang, Shu, Li, Wen-Fei, Chen, Lei, Mao, Yan-Ping, Guo, Ying, Liu, Qing, Ma, Jun, Tang, Ling-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896227/
https://www.ncbi.nlm.nih.gov/pubmed/31850226
http://dx.doi.org/10.3389/fonc.2019.01343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896227/
https://www.ncbi.nlm.nih.gov/pubmed/31850226
http://dx.doi.org/10.3389/fonc.2019.01343

Ejemplares similares